We are convinced that comprehending the tissue-specific impact brought by FD to cellular pathways and metabolism, including cathepsin-related autophagic control, shall be rewarding for disease manifestation and pave the way to developing the strategies tailoring therapeutic interventions to target specific tissues or organs. This evidence concerns the gene CTSS and Fabry disease.